$8.42
-0.04-0.47%
Pre-Market: 7:23 PM EDT
15 minutes delayed
Comments
Loading...
INmune Bio
INMBNASDAQ
INmune Bio (NASDAQ:INMB) Stock, Analyst Ratings, Price Targets, Forecasts
INmune Bio Inc has a consensus price target of $12.33 based on the ratings of 3 analysts. The high is $16 issued by Baird on June 1, 2023. The low is $7 issued by B. Riley Securities on May 24, 2022. The 3 most-recent analyst ratings were released by Baird, BTIG, and B. Riley Securities on June 1, 2023, May 24, 2022, and May 24, 2022, respectively. With an average price target of $12.33 between Baird, BTIG, and B. Riley Securities, there's an implied 46.48% upside for INmune Bio Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Baird
BTIG
B. Riley Securities
1calculated from analyst ratings
Analyst Ratings for INmune Bio
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 06/01/2023 | Buy Now | 90.02% | Baird | Joel Beatty | → $16 | Initiates | → Outperform | Get Alert |
| 05/24/2022 | Buy Now | 66.27% | BTIG | Thomas Shrader | $31 → $14 | Maintains | Buy | Get Alert |
| 05/24/2022 | Buy Now | -16.86% | B. Riley Securities | Mayank Mamtani | $14 → $7 | Downgrade | Buy → Neutral | Get Alert |
| 01/24/2022 | Buy Now | 137.53% | B. Riley Securities | Mayank Mamtani | $32 → $20 | Maintains | Buy | Get Alert |
FAQ
What is the target price for INmune Bio (INMB) stock?
The latest price target for INmune Bio (NASDAQ:INMB) was reported by Baird on June 1, 2023. The analyst firm set a price target for $16.00 expecting INMB to rise to within 12 months (a possible 90.02% upside). 0 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for INmune Bio (INMB)?
The latest analyst rating for INmune Bio (NASDAQ:INMB) was provided by Baird, and INmune Bio initiated their outperform rating.
When was the last upgrade for INmune Bio (INMB)?
There is no last upgrade for INmune Bio
When was the last downgrade for INmune Bio (INMB)?
The last downgrade for INmune Bio Inc happened on May 24, 2022 when B. Riley Securities changed their price target from $14 to $7 for INmune Bio Inc.
When is the next analyst rating going to be posted or updated for INmune Bio (INMB)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of INmune Bio, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for INmune Bio was filed on June 1, 2023 so you should expect the next rating to be made available sometime around June 1, 2024.
Is the Analyst Rating INmune Bio (INMB) correct?
While ratings are subjective and will change, the latest INmune Bio (INMB) rating was a initiated with a price target of $0.00 to $16.00. The current price INmune Bio (INMB) is trading at is $8.42, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.